PubRank

P Dello Russo

Author PubWeight™ 16.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost 1990 1.40
2 Impaired glucose metabolism in heroin and methadone users. Horm Metab Res 1987 1.07
3 Metabolic control may influence the increased superoxide generation in diabetic serum. Diabet Med 1991 0.92
4 Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988 0.88
5 Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. Diabetologia 1982 0.87
6 Depressed antithrombin III biological activity in opiate addicts. J Clin Pathol 1984 0.83
7 Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. Thromb Haemost 1983 0.82
8 Glycosaminoglycans in human diabetes. Diabete Metab 1983 0.81
9 Fibrinogen levels in opiate addicts. Thromb Haemost 1983 0.80
10 Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care 1984 0.80
11 Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes 1987 0.79
12 The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. Diabet Med 1990 0.79
13 Haemoglobin A1 in addicts. Ann Intern Med 1982 0.79
14 Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation. Diabetes Care 1986 0.79
15 Morphine, diabetes, and lipid metabolism. Arch Intern Med 1983 0.79
16 Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. Acta Diabetol Lat 1989 0.78
17 Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation. Diabete Metab 1987 0.78
18 Increased glycosylated proteins in opiate addicts. Diabetes Care 1984 0.78
19 Sod and GSH inhibit the high glucose-induced oxidative damage and the PDGF increased secretion in cultured human endothelial cells. Thromb Haemost 1995 0.76
20 Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 1989 0.76
21 Evidence for a reduced heparin cofactor II biological activity in diabetes. Haemostasis 1990 0.75
22 Increased alpha-2-macroglobulin in opiate addicts: further evidence of an alteration in the coagulation system due to opiate addiction. Acta Haematol 1985 0.75
23 A preliminary note on inhibiting effect of alpha-tocopherol (vit. E) on protein glycation. Diabete Metab 1988 0.75
24 Non-enzymatic glycosylation reduces antithrombin III activity. Thromb Haemost 1984 0.75
25 Increased labile hemoglobin glycosylation in opiate addicts: an unclear phenomenon. Diabete Metab 1985 0.75
26 Reticulocyte counts and haemoglobin glycosylation in diabetes. Diabete Metab 1984 0.75
27 Hyperglycemia-conditioned increase in alpha-2-macroglobulin in healthy normal subjects: a phenomenon correlated with deficient antithrombin III activity. Acta Haematol 1989 0.75
28 Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics. Haemostasis 1986 0.75
29 Influence of labile glucose adducts on glycosylated protein assay by aminophenylboronic acid affinity chromatography: in vivo studies. Acta Diabetol Lat 1985 0.75
30 Red blood cell volume and glycaemic control in diabetes. Diabetologia 1983 0.75
31 Increased red cell volume in impaired glucose tolerance: a further evidence of hematologic sequelae of altered glucose metabolism. Diabetes Care 1985 0.75
32 Acetylsalicylic acid and lysine inhibit protein glycosylation in vitro. A preliminary report. Diabete Metab 1985 0.75
33 Hypertension and diabetes: an hypothesis on the possible role of hyperglycemia. Diabete Metab 1989 0.75
34 Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics. Int J Clin Pharmacol Ther Toxicol 1983 0.75
35 Mean red blood cell volume, narcotic addiction, and glucose tolerance. Arch Intern Med 1985 0.75